✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Akeso Inc

Common Name
Akeso
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
3,529
Ticker
9926
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating ...

Akeso's Financial Statements Preview

Below are the financial statements of Akeso, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of CNY
2024
2023
Commercial sales
2,044.41a
1,631.11a
License income
121.58a
2,922.78a
Total income from commercial sales and licenses
2,165.99a
4,553.89a
Less: distribution cost
-42.04a
-27.63a
Revenue
2,123.94a
4,526.25a
Cost of sales
-289.04a
-133.25a
Gross profit
1,834.9a
4,393.01a
Other income and gains, net
365.99a
454.18a
Research and development expenses
-1,187.69a
-1,254.02a
Selling and marketing expenses
-1,001.79a
-890.38a
Administrative expenses
-203.64a
-200.09a
Share of loss of a long-term equity investment
-68.51a
-191.72a
Other expenses, net
-172.09a
-281.45a
Finance costs
-68.26a
-86.99a
(Loss)/profit before tax
-501.09a
1,942.53a
Income tax expense
0a
-0.17a
(Loss)/profit for the year
-501.09a
1,942.35a
(Loss)/profit attributable to:
Owners of the parent
-514.52a
2,028.3a
Non-controlling interests
13.42a
-85.95a
Limited Data Preview
You are viewing a limited preview of Akeso’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Akeso’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Akeso’s data sources below and access millions more through our Disclosure Search.

a. Akeso's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?